AlphaCentric Life Sciences And Healthcare Fund ABBV Holdings History
AlphaCentric Life Sciences and Healthcare Fund's AbbVie Inc Holding Summary
As of 2025-03-31, AlphaCentric Life Sciences and Healthcare Fund held 10,498.00 shares of AbbVie Inc(ABBV), totaling $2.20 Mil. This investment constitutes 5.08% of their stock portfolio, and AlphaCentric Life Sciences and Healthcare Fund now holds 0% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2019Q4. And since then AlphaCentric Life Sciences and Healthcare Fund has made 2 purchases of ABBV, at an average price of $179.30, for a total of 13,618.00 shares. In addition, there have been 3 sales at an average price of $177.50 for 3,120.00 shares. Based on historical transaction data and ABBV's current price of $187.11, AlphaCentric Life Sciences and Healthcare Fund's estimated gain on his ABBV holdings is $76,433.58, reflecting a 3.13% gain to date.
AlphaCentric Life Sciences and Healthcare Fund ABBV ($187.11) Holding Chart
AlphaCentric Life Sciences and Healthcare Fund ABBV ($187.11) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1